Bernd Rosenkranz

Clinical Development

Jerini AG, Invalidenstr. 130,




Bernd Rosenkranz, FFPM, MD, PhD, is vice president, Clinical Development, Jerini AG, Invalidenstr. 130, D-10115, Berlin, Germany, +49 30 97893 500, fax +49 30 97893 599, email:


Biomarkers and Surrogate Endpoints in Clinical Drug Development

July 01, 2003

Both large and small pharmaceutical companies have learned that the value of their development candidates increases once clinical research has demonstrated their proof of concept. Sponsor companies face the challenge of moving new blockbuster drugs to market as rapidly as possible.